PHI with Dermatosclerosis
How does this condition affect your private health insurance?
Dermatosklerose, or dermatosclerosis, refers to the hardening and thickening of the skin due to excessive collagen deposition. It is a hallmark feature of systemic sclerosis (scleroderma), an autoimmune connective tissue disease. The condition can manifest as localized patches (morphea) or diffusely affect large areas, often starting on the fingers and extending proximally. Beyond skin, systemic forms can impact internal organs like the lungs, heart, kidneys, and gastrointestinal tract, leading to significant morbidity and mortality. Symptoms include skin tightness, reduced mobility, Raynaud's phenomenon, and potential organ dysfunction. Early diagnosis and management are crucial to mitigate progression and complications, though a cure remains elusive.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Weeks to months for initial noticeable skin changes and symptom onset
Duration of Illness (Lifetime)
Chronic and often progressive, lifelong condition for systemic forms; localized forms may remit but often leave residual changes
Cost of Treatment (Initial)
Moderate (e.g., several thousand USD for diagnosis and initial management)
Cost of Treatment (Lifetime)
High to very high (e.g., tens of thousands to hundreds of thousands USD, depending on severity and organ involvement, often lifelong)
Mortality Rate
Low for localized forms; moderate to high (10-30% within 10 years of diagnosis) for diffuse systemic sclerosis with severe organ involvement
Risk of Secondary Damages
Very high (e.g., skin contractures, digital ulcers, pulmonary fibrosis, cardiac involvement, renal crisis, GI dysmotility, significant functional impairment and psychological distress)
Probability of Full Recovery
Low (rare for systemic forms; localized forms may remit but often leave residual changes and not a 'complete recovery' in the sense of no consequences)
Underlying Disease Risk
High, as it is often a manifestation of systemic sclerosis; may be associated with other autoimmune connective tissue diseases